Trexquant Investment’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
Other funds holding IMCR
KCM
Trexquant Investment's IMCR Position: Q3 2026 in Review
Trexquant Investment increased its Immunocore (IMCR) stake by 135% in Q3 2026, buying an estimated $3.33M and bringing the position to 170,879 shares worth $5.18M. The position accounts for 0.03% of the portfolio, ranked #766.
Trexquant Investment first reported a position in IMCR in Q4 2022 and has held it in 10 quarters since. 130 funds tracked by Wall St. Rank hold IMCR as of Q3 2026.
- Trexquant Investment held 170,879 shares of Immunocore worth $5.18M as of Q3 2026.
- Trexquant Investment bought 98,033 Immunocore shares in Q3 2026, an estimated $3.33M.
- Immunocore made up 0.03% of Trexquant Investment's portfolio in Q3 2026, its #766 holding.
- Trexquant Investment first reported a position in Immunocore in Q4 2022 and has held it in 10 quarters since.
- 130 funds tracked by Wall St. Rank held Immunocore as of Q3 2026.
Based on Trexquant Investment's 13F filing for Q3 2026, filed 16 Nov 2026.